4.5 Article

Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency

Journal

LIPIDS IN HEALTH AND DISEASE
Volume 17, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12944-018-0721-9

Keywords

Recombinant human growth hormone; Relative growth hormone deficiency; Obese children

Funding

  1. Jin Lei Pediatric Endocrinology Growth Research Fund for Young Physicians (PEGRF) [PEGRF-SD-20171006]

Ask authors/readers for more resources

Background: Based on the sample of obese children with relative growth hormone deficiency (GHD), the objective of our study was to determine the effects of rhGH treatment on cardiovascular risk factors, including body mass index (BMI), lipid levels and glucose metabolism index. Methods: A total of 43 obese children with relative GHD were included in our final analysis. The obese subjects were divided into two groups: recombinant human growth hormone (rhGH) treatment group and untreated control group. Results: After 6 months, subjects in the rhGH treatment group had significant reductions in BMI standard deviation scores (SDS) compared with controls (2.32 +/- 0.85 vs. 2.80 +/- 0.61; P = 0.041), and Insulin-like growth factor 1(IGF-1) level increased during rhGH treatment, in comparison with the control group (702.91 +/- 246.03 vs. 348.30 +/- 131.93 ng/mL, P < 0.001). GH treatment reduced low density lipoprotein cholesterol (LDL-C) (2.20 +/- 0.45 vs. 2. 63 +/- 0.76 mmol/L, P = 0.027), aspartate aminotransferase (AST) (21.26 +/- 5.72 vs. 32.30 +/- 17.68 mmol/L, P = 0.006) as well as alanine aminotransferase (ALT) (16.70 +/- 6.72 vs. 45.20 +/- 46.62 mmol/L, P = 0.002), and increased high density lipoprotein cholesterol (HDL-C) (1.45 +/- 0.40 vs. 1.19 +/- 0.23 mmol/L, P = 0.016) levels compared with the control group. Conclusion: RhGH treatment for 6 months on obese children with relative GHD reduces BMI SDS, stabilize IGF-1 levels, and exerts beneficial effects on blood lipid profiles and live enzyme compared with untreated control group. Moreover, GH administration has no significant effects on increased insulin resistance and no adversely effect on glucose homeostasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available